We here demonstrate that repeatedly mRNA-vaccinated MM patients, particularly those receiving anti-CD38 mAb therapy, showed lower SARS-CoV-2 Wuhan- and Omicron-specific Ab responses and delayed S-specific B memory cell formation, which, however, improved in patients with hybrid immunity. Here, CD38 is linked to Miyoshi myopathy.